DIHYDROERGOTAMINE MESYLATE

DIHYDROERGOTAMINE MESYLATE was reported 1347 times

DIHYDROERGOTAMINE MESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PEDAL PULSE ABSENT 3 0.2308
1 POPLITEAL PULSE DECREASED 2 0.2222
2 NEOVASCULARISATION 40 0.1521
3 SUPERIOR VENA CAVAL STENOSIS 1 0.1111
4 CONGENITAL HAEMATOLOGICAL DISORDER 1 0.0909
5 LIPOGRANULOMA 1 0.0769
6 APPLICATION SITE CYST 1 0.0769
7 HETEROPHORIA 11 0.0759
8 CHRONIC PAROXYSMAL HEMICRANIA 1 0.0714
9 ALPHA GLOBULIN INCREASED 1 0.0500
10 SUNCT SYNDROME 1 0.0455
11 MIGRAINE WITHOUT AURA 11 0.0367
12 ERGOT POISONING 4 0.0320
13 PRODUCT USED FOR UNKNOWN INDICATION 40 0.0318
14 HYPERTENSIVE CARDIOMEGALY 1 0.0312
15 ANISOCORIA 11 0.0291
16 LOCOMOTIVE SYNDROME 1 0.0270
17 VASCULAR GRAFT OCCLUSION 10 0.0260
18 STATUS MIGRAINOSUS 4 0.0248
19 PHONOPHOBIA 11 0.0239
20 MEDIASTINAL FIBROSIS 1 0.0238
21 SARS-COV-2 TEST FALSE POSITIVE 1 0.0227
22 RETROGRADE AMNESIA 11 0.0217
23 DYSCALCULIA 5 0.0202
24 OCCIPITAL NEURALGIA 11 0.0195
25 HYPOAESTHESIA EYE 11 0.0186
26 NASAL MUCOSAL BLISTERING 1 0.0185
27 FIBROADENOMA OF BREAST 8 0.0178
28 ISCHAEMIC NEUROPATHY 1 0.0175
29 CARDIOVASCULAR DECONDITIONING 1 0.0172
30 ELECTROMYOGRAM ABNORMAL 3 0.0166
31 PERIORBITAL DISCOMFORT 1 0.0156
32 MUSCLE FIBROSIS 1 0.0137
33 TONGUE NECROSIS 1 0.0137
34 COAGULATION FACTOR VIII LEVEL INCREASED 2 0.0136
35 SEDATION 339 0.0129
36 NERVE CONDUCTION STUDIES ABNORMAL 2 0.0120
37 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 1 0.0119
38 PARADOXICAL DRUG REACTION 40 0.0109
39 COLON GANGRENE 1 0.0108
40 INTRANASAL HYPOAESTHESIA 1 0.0106
41 CLUSTER HEADACHE 14 0.0102
42 HAEMODILUTION 1 0.0101
43 NIGHTMARE 339 0.0098
44 MELANOSIS COLI 1 0.0086
45 PREALBUMIN DECREASED 1 0.0083
46 RENAL REPLACEMENT THERAPY 1 0.0078
47 ANTACID THERAPY 1 0.0077
48 POSTMATURE BABY 1 0.0068
49 POST PROCEDURAL CONSTIPATION 1 0.0068
50 URETHRAL INJURY 1 0.0065
51 CONFUSIONAL AROUSAL 1 0.0062
52 OESOPHAGOGASTRIC FUNDOPLASTY 1 0.0059
53 MENOMETRORRHAGIA 11 0.0058
54 NEPHROLITHIASIS 252 0.0055
55 PICKWICKIAN SYNDROME 1 0.0053
56 PRODUCT BARCODE ISSUE 2 0.0052
57 EXOPHTHALMOS 11 0.0051
58 GRANULOCYTOSIS 1 0.0051
59 SLEEP DISORDER THERAPY 1 0.0051
60 HEPATITIS A ANTIBODY POSITIVE 1 0.0051
61 PRINZMETAL ANGINA 5 0.0050
62 TRANSFERRIN DECREASED 1 0.0049
63 MONONEUROPATHY 1 0.0048
64 DISSOCIATIVE IDENTITY DISORDER 1 0.0048
65 ANURIA 40 0.0046
66 PRODUCT WITH QUALITY ISSUE ADMINISTERED 2 0.0045
67 VASOSPASM 4 0.0044
68 MIGRAINE WITH AURA 11 0.0040
69 NASAL DISCOMFORT 32 0.0040
70 CLUMSINESS 11 0.0040
71 MONONUCLEOSIS SYNDROME 1 0.0039
72 BLOOD CHOLINESTERASE DECREASED 1 0.0036
73 GROIN INFECTION 2 0.0036
74 EYE INJURY 11 0.0036
75 ANTICOAGULANT THERAPY 1 0.0035
76 MENOPAUSAL SYMPTOMS 8 0.0034
77 NERVE BLOCK 2 0.0034
78 MYOPIA 8 0.0034
79 BIOPSY LIVER ABNORMAL 1 0.0033
80 EXTENSOR PLANTAR RESPONSE 3 0.0033
81 BED REST 1 0.0032
82 PRODUCT AFTER TASTE 3 0.0031
83 ANALGESIC THERAPY 1 0.0031
84 DRUG THERAPY 1 0.0029
85 FALLOT'S TETRALOGY 1 0.0029
86 COMMUNICATION DISORDER 11 0.0029
87 MENTAL RETARDATION 1 0.0028
88 NASAL INFLAMMATION 3 0.0028
89 HYPOCHOLESTEROLAEMIA 1 0.0028
90 CARDIAC ENZYMES INCREASED 2 0.0028
91 HYPERHIDROSIS 356 0.0028
92 HYPERTRICHOSIS 5 0.0027
93 APPENDICOLITH 1 0.0026
94 FAT TISSUE DECREASED 1 0.0026
95 RHINALGIA 7 0.0025
96 RADIUS FRACTURE 6 0.0025
97 SINONASAL OBSTRUCTION 1 0.0025
98 VULVOVAGINAL DRYNESS 8 0.0025
99 HYPOXIC ENCEPHALOPATHY 1 0.0024
100 HYPOCAPNIA 1 0.0024
101 PHOTODERMATOSIS 1 0.0024
102 MEDICATION OVERUSE HEADACHE 2 0.0023
103 VASOCONSTRICTION 2 0.0023
104 HERNIA PAIN 1 0.0022
105 PHARYNGEAL HYPOAESTHESIA 2 0.0022
106 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
107 ATRIOVENTRICULAR SEPTAL DEFECT 1 0.0021
108 PULMONARY VASCULAR DISORDER 1 0.0021
109 BLEPHAROSPASM 13 0.0021
110 BLOOD URIC ACID DECREASED 1 0.0021
111 AMNESTIC DISORDER 1 0.0021
112 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 4 0.0020
113 ASTHENOPIA 11 0.0020
114 INTERMENSTRUAL BLEEDING 11 0.0020
115 ACCIDENT AT HOME 1 0.0019
116 INTERMITTENT CLAUDICATION 3 0.0019
117 INADEQUATE DIET 1 0.0019
118 HYDROCEPHALUS 10 0.0018
119 MACROGLOSSIA 1 0.0018
120 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 1 0.0018
121 HEPATITIS C VIRUS 1 0.0018
122 CATHETER SITE INFLAMMATION 1 0.0018
123 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
124 GALLBLADDER NON-FUNCTIONING 1 0.0018
125 RETROPERITONEAL FIBROSIS 1 0.0017
126 EXTRAPYRAMIDAL DISORDER 42 0.0017
127 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
128 NASAL OEDEMA 3 0.0017
129 SUPERIOR VENA CAVA SYNDROME 1 0.0017
130 SACRAL PAIN 1 0.0016
131 EYE MOVEMENT DISORDER 11 0.0016
132 BACILLUS INFECTION 1 0.0016
133 HYPERCHLORAEMIA 1 0.0016
134 PHAEOCHROMOCYTOMA 1 0.0015
135 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
136 THROAT LESION 1 0.0015
137 OVERLAP SYNDROME 1 0.0014
138 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
139 FACIAL DISCOMFORT 1 0.0014
140 CERVIX DISORDER 1 0.0014
141 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
142 NASAL CONGESTION 81 0.0014
143 CEREBRAL VASOCONSTRICTION 1 0.0014
144 RESPIRATORY TRACT OEDEMA 1 0.0013
145 CHOLANGITIS ACUTE 1 0.0013
146 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
147 SINUS PAIN 3 0.0013
148 FOETAL GROWTH RETARDATION 1 0.0013
149 CHRONIC HEPATITIS 1 0.0012
150 ENDOMETRIAL HYPERPLASIA 1 0.0012
151 PSEUDOMONAS TEST POSITIVE 1 0.0012
152 LIGAMENT SPRAIN 12 0.0012
153 NEONATAL HYPOXIA 1 0.0012
154 ILLUSION 2 0.0012
155 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
156 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
157 WOUND INFECTION 13 0.0012
158 PRODUCT USE IN UNAPPROVED INDICATION 293 0.0012
159 EYELID PTOSIS 12 0.0012
160 HEPATITIS A 1 0.0012
161 INFECTED BITE 1 0.0012
162 ALLERGIC SINUSITIS 1 0.0012
163 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
164 MIGRAINE 110 0.0012
165 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
166 VISUAL FIELD DEFECT 8 0.0011
167 PLACENTAL DISORDER 1 0.0011
168 HEPATIC CONGESTION 1 0.0011
169 PARANASAL SINUS DISCOMFORT 4 0.0011
170 TENDERNESS 11 0.0011
171 VASCULAR PAIN 1 0.0010
172 PYELOCALIECTASIS 1 0.0010
173 VAGINAL DISORDER 1 0.0010
174 HAIR GROWTH ABNORMAL 7 0.0010
175 SKIN OEDEMA 1 0.0010
176 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
177 AUTONOMIC NEUROPATHY 1 0.0010
178 TONGUE BITING 2 0.0010
179 BREAST NEOPLASM 1 0.0010
180 ALVEOLITIS ALLERGIC 1 0.0010
181 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
182 COORDINATION ABNORMAL 13 0.0009
183 HYPERPHOSPHATAEMIA 2 0.0009
184 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 1 0.0009
185 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
186 OPEN WOUND 1 0.0009
187 HEAVY MENSTRUAL BLEEDING 8 0.0009
188 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
189 MYDRIASIS 11 0.0009
190 LABILE BLOOD PRESSURE 1 0.0008
191 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
192 EMBOLISM ARTERIAL 1 0.0008
193 TOOTH EROSION 1 0.0008
194 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
195 TACHYARRHYTHMIA 2 0.0008
196 OVARIAN CYST 8 0.0008
197 NASAL PRURITUS 1 0.0008
198 LUPUS VULGARIS 1 0.0008
199 FACIAL PAIN 7 0.0008
200 APGAR SCORE LOW 1 0.0008
201 SINUS ARRHYTHMIA 1 0.0008
202 APATHY 11 0.0008
203 ARTERIOSPASM CORONARY 3 0.0007
204 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
205 PHOTOPHOBIA 14 0.0007
206 SINUS CONGESTION 10 0.0007
207 EFFUSION 1 0.0007
208 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
209 INFUSION SITE RASH 1 0.0007
210 SUDDEN ONSET OF SLEEP 1 0.0007
211 DEATH NEONATAL 1 0.0007
212 PROTHROMBIN TIME SHORTENED 1 0.0007
213 BRONCHIAL OBSTRUCTION 1 0.0007
214 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
215 MENINGIOMA 11 0.0007
216 TREATMENT FAILURE 58 0.0007
217 IMPAIRED QUALITY OF LIFE 10 0.0007
218 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
219 PULMONARY VALVE INCOMPETENCE 1 0.0007
220 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
221 HEART VALVE REPLACEMENT 1 0.0007
222 ADHESION 1 0.0007
223 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
224 DAYDREAMING 1 0.0006
225 POLYCYSTIC OVARIES 1 0.0006
226 BRONCHIAL DISORDER 1 0.0006
227 NEONATAL DISORDER 1 0.0006
228 NASAL ULCER 1 0.0006
229 AMENORRHOEA 11 0.0006
230 TOTAL LUNG CAPACITY DECREASED 1 0.0006
231 SKULL FRACTURE 1 0.0006
232 DENTAL IMPLANTATION 1 0.0006
233 HYPERAESTHESIA 5 0.0006
234 DISABILITY 12 0.0006
235 COLONIC POLYP 1 0.0006
236 ANTIBODY TEST POSITIVE 1 0.0006
237 CYTOLYTIC HEPATITIS 2 0.0006
238 TROPONIN I INCREASED 1 0.0006
239 GAZE PALSY 1 0.0006
240 DIFFICULTY IN WALKING 2 0.0006
241 HYPOCALCAEMIA 11 0.0006
242 SPINAL CORD INJURY 1 0.0006
243 EAR PRURITUS 2 0.0006
244 MUSCLE TWITCHING 13 0.0006
245 CONJUNCTIVAL HYPERAEMIA 2 0.0006
246 APPLICATION SITE DISCOMFORT 1 0.0006
247 OROPHARYNGEAL DISCOMFORT 5 0.0006
248 UPPER LIMB FRACTURE 11 0.0006
249 MAJOR DEPRESSION 4 0.0005
250 HYPERSEXUALITY 1 0.0005
251 ESSENTIAL HYPERTENSION 1 0.0005
252 DIPLOPIA 14 0.0005
253 LYMPH NODE PAIN 1 0.0005
254 BLOOD CHOLESTEROL DECREASED 1 0.0005
255 TROPONIN INCREASED 4 0.0005
256 HYPERCOAGULATION 1 0.0005
257 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
258 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
259 CLEFT PALATE 1 0.0005
260 SENSATION OF HEAVINESS 2 0.0005
261 IMPAIRED WORK ABILITY 11 0.0005
262 SINUS HEADACHE 3 0.0005
263 NAUSEA 398 0.0005
264 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
265 HEPATITIS CHOLESTATIC 3 0.0005
266 HYPERPARATHYROIDISM 1 0.0005
267 LIMB DISCOMFORT 15 0.0005
268 DILATATION VENTRICULAR 1 0.0005
269 NEUROGENIC BLADDER 1 0.0005
270 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
271 TONGUE DISCOLOURATION 2 0.0005
272 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
273 MIDDLE EAR EFFUSION 1 0.0005
274 PRODUCT LOT NUMBER ISSUE 1 0.0005
275 PARESIS 1 0.0004
276 NERVOUS SYSTEM DISORDER 14 0.0004
277 DRUG INEFFECTIVE 591 0.0004
278 HEPATOCELLULAR DAMAGE 1 0.0004
279 MITRAL VALVE INCOMPETENCE 5 0.0004
280 PERIARTHRITIS 1 0.0004
281 HAEMATOCRIT INCREASED 1 0.0004
282 DYSPEPSIA 43 0.0004
283 PERIPHERAL COLDNESS 6 0.0004
284 HAEMANGIOMA 1 0.0004
285 INFUSION SITE INFECTION 1 0.0004
286 UTERINE DISORDER 1 0.0004
287 PATELLA FRACTURE 1 0.0004
288 PULMONARY INFARCTION 1 0.0004
289 PULSE ABSENT 2 0.0004
290 OFF LABEL USE 367 0.0004
291 URINARY HESITATION 1 0.0004
292 PULSE ABNORMAL 1 0.0004
293 TRANSPLANT FAILURE 1 0.0004
294 NIGHT SWEATS 13 0.0004
295 INJECTION SITE ABSCESS 1 0.0004
296 INJECTION SITE INFLAMMATION 2 0.0004
297 CATHETER SITE HAEMORRHAGE 1 0.0004
298 HEAD DISCOMFORT 7 0.0004
299 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
300 PARKINSON'S DISEASE 1 0.0004
301 EPILEPSY 12 0.0004
302 HEPATOSPLENOMEGALY 1 0.0004
303 DRUG TITRATION ERROR 1 0.0004
304 COMPARTMENT SYNDROME 1 0.0004
305 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
306 LUNG OPACITY 1 0.0004
307 POLYARTHRITIS 2 0.0004
308 MOVEMENT DISORDER 12 0.0004
309 BRUXISM 2 0.0004
310 BLOOD SODIUM INCREASED 1 0.0004
311 BRADYPNOEA 1 0.0004
312 SKIN LACERATION 4 0.0004
313 CLONUS 1 0.0004
314 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
315 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
316 CHOKING SENSATION 2 0.0004
317 THERAPEUTIC RESPONSE DELAYED 1 0.0004
318 ACUTE PULMONARY OEDEMA 2 0.0004
319 PSYCHOMOTOR RETARDATION 1 0.0004
320 SKIN HYPERTROPHY 1 0.0004
321 PERIORBITAL SWELLING 2 0.0004
322 OESOPHAGEAL STENOSIS 1 0.0004
323 PRODUCT CONTAINER ISSUE 3 0.0003
324 HYPERTONIA 2 0.0003
325 HEART VALVE INCOMPETENCE 1 0.0003
326 HYPOGLYCAEMIC COMA 1 0.0003
327 RALES 2 0.0003
328 CAESAREAN SECTION 4 0.0003
329 HEPATITIS FULMINANT 1 0.0003
330 HEPATITIS B 2 0.0003
331 EXPIRED PRODUCT ADMINISTERED 11 0.0003
332 VARICES OESOPHAGEAL 1 0.0003
333 INVESTIGATION 1 0.0003
334 BRAIN FOG 5 0.0003
335 PRODUCT USE COMPLAINT 5 0.0003
336 HIATUS HERNIA 4 0.0003
337 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
338 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
339 THROMBOSIS IN DEVICE 1 0.0003
340 URINARY INCONTINENCE 9 0.0003
341 CRYING 11 0.0003
342 EYE PAIN 17 0.0003
343 CARDIAC FAILURE ACUTE 2 0.0003
344 POST-TRAUMATIC STRESS DISORDER 2 0.0003
345 TOXIC SKIN ERUPTION 3 0.0003
346 COLITIS ISCHAEMIC 2 0.0003
347 NEOPLASM RECURRENCE 1 0.0003
348 LEFT VENTRICULAR FAILURE 1 0.0003
349 DROOLING 2 0.0003
350 HYPOPNOEA 1 0.0003
351 FORMICATION 2 0.0003
352 AORTIC STENOSIS 1 0.0003
353 HYPERREFLEXIA 1 0.0003
354 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
355 COGNITIVE DISORDER 13 0.0003
356 LIVER TRANSPLANT 1 0.0003
357 ORAL DISORDER 2 0.0003
358 HYPOPHOSPHATAEMIA 2 0.0003
359 BLINDNESS 11 0.0003
360 NEURODERMATITIS 1 0.0003
361 CHRONIC SINUSITIS 1 0.0003
362 HEPATIC NECROSIS 1 0.0003
363 FACE INJURY 1 0.0003
364 PARANASAL SINUS HYPERSECRETION 1 0.0003
365 ACIDOSIS 2 0.0003
366 THROAT TIGHTNESS 7 0.0003
367 CONGENITAL ANOMALY 2 0.0003
368 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
369 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
370 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
371 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
372 BLOOD ALBUMIN DECREASED 2 0.0003
373 CEREBRAL ATROPHY 1 0.0003
374 NECK PAIN 14 0.0003
375 OBSTRUCTION 1 0.0003
376 CANDIDIASIS 1 0.0002
377 TRIGEMINAL NEURALGIA 1 0.0002
378 ENURESIS 1 0.0002
379 SPINAL FUSION SURGERY 1 0.0002
380 PERIPHERAL ISCHAEMIA 1 0.0002
381 HALLUCINATIONS, MIXED 1 0.0002
382 AORTIC VALVE INCOMPETENCE 1 0.0002
383 TENSION HEADACHE 1 0.0002
384 MYOPATHY 2 0.0002
385 MONOPLEGIA 1 0.0002
386 VERTIGO 14 0.0002
387 DISCOMFORT 14 0.0002
388 EOSINOPHILIA 4 0.0002
389 BLOOD CREATINE INCREASED 1 0.0002
390 THROAT IRRITATION 10 0.0002
391 DEVELOPMENTAL DELAY 2 0.0002
392 SUSPECTED OFF LABEL USE 1 0.0002
393 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
394 PRODUCT AVAILABILITY ISSUE 5 0.0002
395 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
396 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
397 ISCHAEMIA 1 0.0002
398 MEDICATION ERROR 12 0.0002
399 AMNESIA 14 0.0002
400 ABDOMINAL PAIN 50 0.0002
401 ROSACEA 1 0.0002
402 FEELING OF DESPAIR 1 0.0002
403 WITHDRAWAL SYNDROME 9 0.0002
404 APPENDICITIS 2 0.0002
405 LACERATION 2 0.0002
406 BLOOD PROLACTIN INCREASED 1 0.0002
407 SPINAL COLUMN STENOSIS 1 0.0002
408 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
409 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
410 PRODUCT PACKAGING ISSUE 2 0.0002
411 FEELING JITTERY 4 0.0002
412 SLEEP APNOEA SYNDROME 4 0.0002
413 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
414 KIDNEY TRANSPLANT REJECTION 1 0.0002
415 FAECAL INCONTINENCE 1 0.0002
416 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
417 VITAMIN D DEFICIENCY 2 0.0002
418 PHARYNGEAL SWELLING 2 0.0002
419 HAEMATOCRIT DECREASED 4 0.0002
420 SALIVARY HYPERSECRETION 2 0.0002
421 CORONARY ARTERY STENOSIS 1 0.0002
422 SLEEP DISORDER 14 0.0002
423 OSTEOPENIA 3 0.0002
424 ILL-DEFINED DISORDER 12 0.0002
425 PETIT MAL EPILEPSY 1 0.0002
426 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
427 CACHEXIA 1 0.0002
428 POOR VENOUS ACCESS 2 0.0002
429 PETECHIAE 2 0.0002
430 TACHYCARDIA 17 0.0002
431 WEIGHT FLUCTUATION 2 0.0002
432 SERUM FERRITIN INCREASED 1 0.0002
433 HOT FLUSH 14 0.0002
434 CHEILITIS 1 0.0002
435 HIP SURGERY 1 0.0002
436 OSTEONECROSIS 6 0.0002
437 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
439 GASTRIC ULCER HAEMORRHAGE 1 0.0002
440 INTRACRANIAL PRESSURE INCREASED 1 0.0002
441 ANGIOPATHY 1 0.0002
442 SNEEZING 4 0.0002
443 PREMATURE LABOUR 1 0.0002
444 METRORRHAGIA 3 0.0002
445 DYSGEUSIA 13 0.0002
446 NEUROLOGICAL SYMPTOM 1 0.0002
447 CARDIAC VALVE DISEASE 1 0.0002
448 COUGH 49 0.0002
449 MOUTH SWELLING 1 0.0002
450 HYPERVENTILATION 1 0.0002
451 ORTHOSTATIC HYPOTENSION 3 0.0002
452 METABOLIC DISORDER 1 0.0002
453 PRODUCT LABEL CONFUSION 1 0.0002
454 BURNING SENSATION 12 0.0002
455 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
456 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
457 PROTHROMBIN TIME PROLONGED 1 0.0002
458 WEIGHT DECREASED 46 0.0002
459 NEURALGIA 4 0.0002
460 DRUG ABUSER 1 0.0002
461 LARYNGEAL OEDEMA 1 0.0002
462 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
463 PRE-EXISTING CONDITION IMPROVED 1 0.0002
464 SWELLING OF EYELID 1 0.0002
465 SCREAMING 1 0.0002
466 GALACTORRHOEA 1 0.0002
467 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
468 DYSPNOEA 88 0.0002
469 ANOREXIA 2 0.0002
470 RASH GENERALISED 4 0.0002
471 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
472 HERPES SIMPLEX 1 0.0002
473 PARAESTHESIA 24 0.0002
474 DYSGRAPHIA 1 0.0002
475 SINUS DISORDER 3 0.0002
476 DRUG INTERACTION 24 0.0002
477 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
478 BALANCE DISORDER 13 0.0002
479 FUNGAL INFECTION 5 0.0001
480 SKIN MASS 1 0.0001
481 MENINGITIS 1 0.0001
482 SOMNOLENCE 30 0.0001
483 BREAST MASS 1 0.0001
484 JAUNDICE 4 0.0001
485 PRODUCT TASTE ABNORMAL 2 0.0001
486 PRODUCT LABEL ISSUE 1 0.0001
487 PALLOR 4 0.0001
488 CHEST DISCOMFORT 15 0.0001
489 BLOOD TESTOSTERONE DECREASED 1 0.0001
490 RESPIRATORY DISTRESS 4 0.0001
491 ENCEPHALITIS 1 0.0001
492 FEELING COLD 4 0.0001
493 RIGHT VENTRICULAR FAILURE 1 0.0001
494 APPLICATION SITE REACTION 1 0.0001
495 PAIN IN JAW 4 0.0001
496 HAND FRACTURE 1 0.0001
497 SINUS TACHYCARDIA 2 0.0001
498 DIVERTICULUM 1 0.0001
499 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
500 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
501 CARDIOGENIC SHOCK 2 0.0001
502 DEEP VEIN THROMBOSIS 9 0.0001
503 FLUID OVERLOAD 2 0.0001
504 PANIC ATTACK 5 0.0001
505 MUSCULOSKELETAL STIFFNESS 12 0.0001
506 MOUTH HAEMORRHAGE 1 0.0001
507 ILLNESS 14 0.0001
508 INFLAMMATION 7 0.0001
509 PSYCHIATRIC SYMPTOM 1 0.0001
510 TRANSAMINASES INCREASED 3 0.0001
511 FEELING DRUNK 1 0.0001
512 DUODENAL ULCER PERFORATION 1 0.0001
513 SPEECH DISORDER 7 0.0001
514 HYDRONEPHROSIS 1 0.0001
515 PAROSMIA 1 0.0001
516 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
517 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
518 HYPERTHERMIA 1 0.0001
519 LIPASE INCREASED 1 0.0001
520 DISSOCIATION 1 0.0001
521 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
522 AFFECTIVE DISORDER 1 0.0001
523 CYANOSIS 2 0.0001
524 TRICUSPID VALVE INCOMPETENCE 1 0.0001
525 SCIATICA 2 0.0001
526 RHINITIS 1 0.0001
527 INTERSTITIAL LUNG DISEASE 6 0.0001
528 MYASTHENIA GRAVIS 1 0.0001
529 MUSCLE DISORDER 1 0.0001
530 MUSCLE TIGHTNESS 2 0.0001
531 INJECTION SITE URTICARIA 3 0.0001
532 LETHARGY 7 0.0001
533 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
534 MUSCLE INJURY 1 0.0001
535 TREMOR 20 0.0001
536 EMBOLISM 1 0.0001
537 EOSINOPHIL COUNT INCREASED 1 0.0001
538 LIVE BIRTH 1 0.0001
539 ATRIAL SEPTAL DEFECT 1 0.0001
540 RENAL FAILURE ACUTE 5 0.0001
541 VISION BLURRED 16 0.0001
542 PSYCHOLOGICAL TRAUMA 1 0.0001
543 SKIN SWELLING 1 0.0001
544 RESPIRATORY TRACT INFECTION 3 0.0001
545 BLOOD CALCIUM INCREASED 1 0.0001
546 HYPOXIA 4 0.0001
547 HYPOAESTHESIA 17 0.0001
548 COLD SWEAT 2 0.0001
549 PRODUCT COMMUNICATION ISSUE 1 0.0001
550 LUNG INFILTRATION 1 0.0001
551 PURPURA 1 0.0001
552 LYMPHADENOPATHY 4 0.0001
553 INJECTION SITE BRUISING 9 0.0001
554 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
555 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
556 PREGNANCY WITH CONTRACEPTIVE DEVICE 1 0.0001
557 PAIN OF SKIN 3 0.0001
558 AGITATION 8 0.0001
559 BRAIN NEOPLASM 1 0.0001
560 ANAPHYLACTIC REACTION 6 0.0001
561 IRON DEFICIENCY ANAEMIA 1 0.0001
562 INJECTION SITE MASS 4 0.0001
563 CHEST PAIN 20 0.0001
564 WOUND 3 0.0001
565 HEPATIC ENCEPHALOPATHY 1 0.0001
566 DEFORMITY 1 0.0001
567 DIARRHOEA HAEMORRHAGIC 1 0.0001
568 PRODUCT USE ISSUE 20 0.0001
569 ABORTION INDUCED 1 0.0001
570 FALL 35 0.0001
571 PULMONARY FIBROSIS 2 0.0001
572 POST PROCEDURAL COMPLICATION 2 0.0001
573 SEROTONIN SYNDROME 2 0.0001
574 HYPERCHOLESTEROLAEMIA 1 0.0001
575 SINUS BRADYCARDIA 1 0.0001
576 PRESCRIBED OVERDOSE 2 0.0001
577 DYSTONIA 2 0.0001
578 EAR PAIN 2 0.0001
579 AUTOIMMUNE DISORDER 1 0.0001
580 DIZZINESS 51 0.0001
581 INFLAMMATORY BOWEL DISEASE 1 0.0001
582 HEADACHE 64 0.0001
583 ASCITES 3 0.0001
584 HEPATOMEGALY 1 0.0001
585 ACUTE MYOCARDIAL INFARCTION 3 0.0001
586 DISORIENTATION 4 0.0001
587 INABILITY TO AFFORD MEDICATION 1 0.0001
588 BRAIN INJURY 1 0.0001
589 PRODUCT ADMINISTRATION ERROR 2 0.0001
590 HYPOTHERMIA 1 0.0001
591 TASTE DISORDER 2 0.0001
592 DYSKINESIA 4 0.0001
593 DRY THROAT 1 0.0001
594 TOOTH ABSCESS 1 0.0001
595 EUPHORIC MOOD 1 0.0001
596 INITIAL INSOMNIA 1 0.0001
597 EAR DISCOMFORT 1 0.0001
598 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
599 INJECTION SITE WARMTH 2 0.0001
600 VISUAL IMPAIRMENT 12 0.0001
601 TOOTH LOSS 2 0.0001
602 RHABDOMYOLYSIS 4 0.0001
603 NERVOUSNESS 5 0.0001
604 PRODUCT ODOUR ABNORMAL 1 0.0001
605 FOLLICULITIS 1 0.0001
606 DYSPHAGIA 9 0.0001
607 JOINT DISLOCATION 1 0.0001
608 SUDDEN DEATH 1 0.0001
609 HYPOTHYROIDISM 3 0.0001
610 EPISTAXIS 7 0.0001
611 RHINORRHOEA 6 0.0001
612 DECREASED ACTIVITY 1 0.0001
613 SWELLING FACE 6 0.0001
614 INJECTION SITE SWELLING 7 0.0001
615 ASPIRATION 1 0.0001
616 BLOOD GLUCOSE FLUCTUATION 1 0.0001
617 GASTROINTESTINAL PAIN 1 0.0001
618 TOOTH FRACTURE 1 0.0001
619 DENTAL CARIES 1 0.0001
620 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
621 SKIN DISORDER 3 0.0001
622 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
623 OCULAR DISCOMFORT 1 0.0001
624 PANCREATITIS ACUTE 2 0.0001
625 MALAISE 39 0.0001
626 EYE INFECTION 1 0.0001
627 STATUS EPILEPTICUS 1 0.0001
628 MYOCARDIAL ISCHAEMIA 1 0.0001
629 MICTURITION URGENCY 1 0.0001
630 SHOCK 2 0.0001
631 EYE IRRITATION 5 0.0001
632 DELIRIUM 3 0.0001
633 EYELID OEDEMA 1 0.0001
634 VASCULITIS 1 0.0001
635 DYSPHONIA 5 0.0001
636 HEART RATE DECREASED 3 0.0001
637 SPLENOMEGALY 1 0.0001
638 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
639 BLOOD IRON DECREASED 1 0.0001
640 ATAXIA 1 0.0001
641 CEREBRAL HAEMORRHAGE 3 0.0001
642 HYPERLIPIDAEMIA 1 0.0001
643 GAIT DISTURBANCE 16 0.0001
644 POLYNEUROPATHY 1 0.0001
645 DEPRESSION 19 0.0001
646 VOMITING 39 0.0001
647 ADRENAL INSUFFICIENCY 1 0.0001
648 DIARRHOEA 53 0.0001
649 NO THERAPEUTIC RESPONSE 1 0.0001
650 FEELING HOT 5 0.0001
651 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
652 CARDIOMEGALY 1 0.0001
653 INJECTION SITE EXTRAVASATION 1 0.0001
654 HYPERCALCAEMIA 1 0.0001
655 GENERALISED OEDEMA 1 0.0001
656 PHARYNGITIS 1 0.0001
657 CYST 1 0.0001
658 TOOTH EXTRACTION 1 0.0001
659 INJECTION SITE DISCOLOURATION 1 0.0001
660 SECRETION DISCHARGE 1 0.0001
661 DERMATITIS ALLERGIC 1 0.0001
662 FEELING ABNORMAL 19 0.0001
663 HAEMATEMESIS 2 0.0001
664 CARDIOVASCULAR DISORDER 2 0.0001
665 INFUSION SITE PAIN 1 0.0001
666 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
667 BEDRIDDEN 1 0.0001
668 TOOTH INFECTION 1 0.0001
669 PULMONARY CONGESTION 1 0.0001
670 DYSMENORRHOEA 1 0.0001
671 HYPERSENSITIVITY 14 0.0001
672 BLOOD PRESSURE DECREASED 5 0.0001
673 DEHYDRATION 10 0.0001
674 EYE HAEMORRHAGE 1 0.0001
675 JOINT RANGE OF MOTION DECREASED 1 0.0001
676 QUALITY OF LIFE DECREASED 1 0.0001
677 BLOOD BILIRUBIN INCREASED 2 0.0001
678 ANAEMIA 14 0.0001
679 IMPAIRED GASTRIC EMPTYING 1 0.0001
680 ACUTE HEPATIC FAILURE 1 0.0001
681 CORONARY ARTERY OCCLUSION 1 0.0001
682 INJECTION SITE REACTION 5 0.0001
683 ROAD TRAFFIC ACCIDENT 3 0.0001
684 MASS 1 0.0001
685 CARPAL TUNNEL SYNDROME 1 0.0001
686 BLOOD TEST ABNORMAL 1 0.0001
687 SKIN REACTION 1 0.0001
688 HEPATOCELLULAR INJURY 1 0.0001
689 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
690 BRONCHOSPASM 1 0.0001
691 RED BLOOD CELL COUNT DECREASED 2 0.0001
692 PARALYSIS 1 0.0001
693 ASTHENIA 26 0.0001
694 ANOSMIA 1 0.0001
695 HYPERTHYROIDISM 1 0.0001
696 CONDITION AGGRAVATED 21 0.0001
697 HYPOKINESIA 1 0.0001
698 BACK PAIN 16 0.0001
699 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
700 NEEDLE ISSUE 2 0.0001
701 GASTROENTERITIS 1 0.0001
702 PALPITATIONS 8 0.0001
703 PAIN IN EXTREMITY 20 0.0001
704 SKIN HAEMORRHAGE 1 0.0001
705 WEIGHT INCREASED 15 0.0001
706 THERAPY NON-RESPONDER 3 0.0001
707 APHASIA 2 0.0001
708 LACRIMATION INCREASED 2 0.0001
709 BLOOD COUNT ABNORMAL 1 0.0001
710 PLEURAL EFFUSION 4 0.0001
711 DRUG DISPENSING ERROR 1 0.0001
712 TINNITUS 3 0.0001
713 HIP ARTHROPLASTY 1 0.0001
714 OROPHARYNGEAL PAIN 6 0.0001
715 INJECTION SITE ERYTHEMA 8 0.0001
716 DELUSION 1 0.0001
717 SWELLING 6 0.0001
718 ARRHYTHMIA 3 0.0001
719 ULCER 1 0.0001
720 SENSORY DISTURBANCE 1 0.0001
721 PAIN 38 0.0001
722 CHOLELITHIASIS 2 0.0001
723 MANIA 1 0.0001
724 GAIT INABILITY 2 0.0001
725 HYPOTENSION 12 0.0001
726 BLOOD UREA INCREASED 1 0.0001
727 INJECTION SITE PRURITUS 4 0.0001
728 FACE OEDEMA 1 0.0001
729 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
730 HEMIPARESIS 1 0.0001
731 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
732 OEDEMA PERIPHERAL 7 0.0001
733 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
734 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
735 GALLBLADDER DISORDER 1 0.0001
736 THERAPY INTERRUPTED 4 0.0001
737 GOUT 1 0.0001
738 OVERDOSE 12 0.0001
739 SYNOVITIS 1 0.0001
740 COMPLICATION OF DEVICE REMOVAL 1 0.0001
741 LEUKOCYTOSIS 1 0.0001
742 FATIGUE 43 0.0001
743 DRUG EFFECT INCOMPLETE 2 0.0001
744 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
745 RESTLESS LEGS SYNDROME 1 0.0001
746 BONE DISORDER 1 0.0001
747 END STAGE RENAL DISEASE 1 0.0001
748 MUSCLE SPASMS 10 0.0001
749 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
750 ADVERSE EVENT 5 0.0001
751 SEPSIS 6 0.0001
752 EYE SWELLING 2 0.0001
753 HEPATIC STEATOSIS 1 0.0001
754 THINKING ABNORMAL 1 0.0001
755 ABDOMINAL DISCOMFORT 9 0.0001
756 BACTERIAL INFECTION 1 0.0001
757 MIDDLE INSOMNIA 1 0.0001
758 DYSARTHRIA 2 0.0001
759 FRACTURE 1 0.0001
760 BLOOD URINE PRESENT 1 0.0001
761 PULMONARY EMBOLISM 5 0.0001
762 INSOMNIA 14 0.0001
763 MUSCULOSKELETAL DISORDER 1 0.0001
764 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
765 DRUG PRESCRIBING ERROR 1 0.0001
766 SEIZURE 6 0.0001
767 MENORRHAGIA 1 0.0001
768 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
769 ARTHRALGIA 21 0.0001
770 BLOOD PRESSURE ABNORMAL 1 0.0001
771 PREGNANCY 1 0.0000
772 INTENTIONAL SELF-INJURY 1 0.0000
773 CONFUSIONAL STATE 8 0.0000
774 SUICIDE ATTEMPT 3 0.0000
775 DRY MOUTH 4 0.0000
776 PSORIATIC ARTHROPATHY 2 0.0000
777 NASOPHARYNGITIS 9 0.0000
778 HAEMOGLOBIN DECREASED 5 0.0000
779 RIB FRACTURE 1 0.0000
780 ABDOMINAL PAIN UPPER 10 0.0000
781 URTICARIA 8 0.0000
782 KNEE ARTHROPLASTY 1 0.0000
783 OSTEOARTHRITIS 2 0.0000
784 RETCHING 1 0.0000
785 IRRITABLE BOWEL SYNDROME 1 0.0000
786 LIVER FUNCTION TEST INCREASED 1 0.0000
787 POOR QUALITY SLEEP 1 0.0000
788 PRURITUS GENERALISED 1 0.0000
789 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
790 PRODUCT STORAGE ERROR 4 0.0000
791 COVID-19 8 0.0000
792 APPLICATION SITE PAIN 1 0.0000
793 INFUSION RELATED REACTION 3 0.0000
794 LIVER DISORDER 2 0.0000
795 RASH MACULO-PAPULAR 1 0.0000
796 HEPATOTOXICITY 1 0.0000
797 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
798 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
799 APPLICATION SITE PRURITUS 1 0.0000
800 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
801 SUICIDAL IDEATION 4 0.0000
802 SKIN DISCOLOURATION 2 0.0000
803 PYREXIA 15 0.0000
804 PERICARDIAL EFFUSION 1 0.0000
805 BLOOD CHOLESTEROL INCREASED 2 0.0000
806 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
807 INJECTION SITE PAIN 13 0.0000
808 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
809 DRUG INTOLERANCE 4 0.0000
810 MYALGIA 7 0.0000
811 FIBROMYALGIA 1 0.0000
812 CEREBRAL INFARCTION 1 0.0000
813 LUNG DISORDER 2 0.0000
814 ABASIA 1 0.0000
815 MYOCARDIAL INFARCTION 7 0.0000
816 DRY EYE 2 0.0000
817 PNEUMONIA ASPIRATION 1 0.0000
818 LEUKOPENIA 2 0.0000
819 AGGRESSION 2 0.0000
820 HALLUCINATION 3 0.0000
821 FLUID RETENTION 2 0.0000
822 BLOOD PRESSURE INCREASED 6 0.0000
823 HYPOPHAGIA 1 0.0000
824 LOSS OF CONSCIOUSNESS 5 0.0000
825 ERECTILE DYSFUNCTION 1 0.0000
826 ERYTHEMA 8 0.0000
827 ANAPHYLACTIC SHOCK 1 0.0000
828 ANXIETY 11 0.0000
829 EXPOSURE VIA SKIN CONTACT 1 0.0000
830 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
831 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
832 APPLICATION SITE ERYTHEMA 1 0.0000
833 JOINT STIFFNESS 1 0.0000
834 ANHEDONIA 1 0.0000
835 BRADYCARDIA 2 0.0000
836 MENSTRUATION IRREGULAR 1 0.0000
837 THROMBOSIS 3 0.0000
838 DRUG EFFECT DECREASED 2 0.0000
839 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
840 RASH PRURITIC 2 0.0000
841 LIMB INJURY 1 0.0000
842 DEPENDENCE 2 0.0000
843 SKIN LESION 1 0.0000
844 ABNORMAL DREAMS 1 0.0000
845 PROCEDURAL PAIN 1 0.0000
846 DRUG ABUSE 3 0.0000
847 ARTHROPATHY 2 0.0000
848 BLISTER 2 0.0000
849 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
850 HYPONATRAEMIA 2 0.0000
851 TARDIVE DYSKINESIA 1 0.0000
852 ASTHMA 4 0.0000
853 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
854 RHEUMATOID ARTHRITIS 4 0.0000
855 INCORRECT DOSE ADMINISTERED 8 0.0000
856 CONVULSION 2 0.0000
857 ANGINA PECTORIS 1 0.0000
858 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
859 DYSSTASIA 1 0.0000
860 SURGERY 2 0.0000
861 LABORATORY TEST ABNORMAL 1 0.0000
862 GASTROINTESTINAL DISORDER 3 0.0000
863 RESPIRATORY DISORDER 1 0.0000
864 IRRITABILITY 2 0.0000
865 PREMATURE BABY 1 0.0000
866 HEPATIC FAILURE 1 0.0000
867 CORONARY ARTERY DISEASE 1 0.0000
868 THERAPEUTIC RESPONSE DECREASED 2 0.0000
869 INJECTION SITE RASH 1 0.0000
870 DRUG ADMINISTRATION ERROR 1 0.0000
871 EMOTIONAL DISORDER 1 0.0000
872 CONSTIPATION 7 0.0000
873 CYSTITIS 1 0.0000
874 METABOLIC ACIDOSIS 1 0.0000
875 BLOOD CREATININE INCREASED 2 0.0000
876 IMPAIRED HEALING 1 0.0000
877 STAPHYLOCOCCAL INFECTION 1 0.0000
878 HEART RATE INCREASED 3 0.0000
879 FEBRILE NEUTROPENIA 2 0.0000
880 URINARY RETENTION 1 0.0000
881 TYPE 2 DIABETES MELLITUS 1 0.0000
882 ANGER 1 0.0000
883 CEREBROVASCULAR ACCIDENT 5 0.0000
884 FLUSHING 3 0.0000
885 PRODUCT QUALITY ISSUE 4 0.0000
886 HEPATIC ENZYME INCREASED 2 0.0000
887 SINUSITIS 3 0.0000
888 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
889 HYPERKALAEMIA 1 0.0000
890 INJURY 2 0.0000
891 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
892 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
893 C-REACTIVE PROTEIN INCREASED 1 0.0000
894 UNDERDOSE 2 0.0000
895 ACCIDENTAL OVERDOSE 1 0.0000
896 PRODUCT DOSE OMISSION ISSUE 8 0.0000
897 DYSURIA 1 0.0000
898 BRONCHITIS 2 0.0000
899 DYSPNOEA EXERTIONAL 1 0.0000
900 INTESTINAL OBSTRUCTION 1 0.0000
901 UNEVALUABLE EVENT 2 0.0000
902 MUSCULAR WEAKNESS 3 0.0000
903 DIABETES MELLITUS 2 0.0000
904 CHILLS 3 0.0000
905 DRUG DOSE OMISSION BY DEVICE 2 0.0000
906 ABNORMAL BEHAVIOUR 1 0.0000
907 RASH 11 0.0000
908 CARDIAC FAILURE CONGESTIVE 2 0.0000
909 JOINT SWELLING 3 0.0000
910 EXTRA DOSE ADMINISTERED 1 0.0000
911 DEVICE BREAKAGE 1 0.0000
912 OSTEOPOROSIS 1 0.0000
913 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
914 CARDIO-RESPIRATORY ARREST 1 0.0000
915 RENAL IMPAIRMENT 2 0.0000
916 URINARY TRACT INFECTION 4 0.0000
917 RECTAL HAEMORRHAGE 1 0.0000
918 DEVICE LEAKAGE 1 0.0000
919 SEPTIC SHOCK 1 0.0000
920 MENTAL DISORDER 1 0.0000
921 INTENTIONAL PRODUCT MISUSE 2 0.0000
922 DRUG WITHDRAWAL SYNDROME 2 0.0000
923 PULMONARY OEDEMA 1 0.0000
924 NO ADVERSE EVENT 4 0.0000
925 MEMORY IMPAIRMENT 3 0.0000
926 SKIN IRRITATION 1 0.0000
927 HYPOKALAEMIA 1 0.0000
928 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
929 PNEUMONIA 7 0.0000
930 DECREASED APPETITE 5 0.0000
931 BLOOD GLUCOSE INCREASED 4 0.0000
932 OCULAR HYPERAEMIA 1 0.0000
933 DISEASE RECURRENCE 1 0.0000
934 PRODUCTIVE COUGH 1 0.0000
935 RASH ERYTHEMATOUS 1 0.0000
936 PRURITUS 8 0.0000
937 ATRIAL FIBRILLATION 2 0.0000
938 ALOPECIA 4 0.0000
939 CELLULITIS 1 0.0000
940 ABDOMINAL DISTENSION 2 0.0000
941 ECZEMA 1 0.0000
942 MUSCULOSKELETAL PAIN 1 0.0000
943 PANCREATITIS 1 0.0000
944 HYPERTENSION 4 0.0000
945 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
946 DISTURBANCE IN ATTENTION 1 0.0000
947 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
948 OEDEMA 1 0.0000
949 TREATMENT NONCOMPLIANCE 1 0.0000
950 INFLUENZA 2 0.0000
951 OXYGEN SATURATION DECREASED 1 0.0000
952 TOXICITY TO VARIOUS AGENTS 3 0.0000
953 HERPES ZOSTER 1 0.0000
954 PRODUCT SUBSTITUTION ISSUE 1 0.0000
955 BONE PAIN 1 0.0000
956 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
957 EXPOSURE DURING PREGNANCY 1 0.0000
958 INTENTIONAL OVERDOSE 1 0.0000
959 DEVICE EXPULSION 1 0.0000
960 PRODUCT DOSE OMISSION 1 0.0000
961 PSORIASIS 2 0.0000
962 DEVICE DIFFICULT TO USE 1 0.0000
963 NEUTROPENIA 2 0.0000
964 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
965 DEVICE MALFUNCTION 1 0.0000
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
967 MOBILITY DECREASED 1 0.0000
968 INFECTION 2 0.0000
969 ARTHRITIS 1 0.0000
970 INJECTION SITE HAEMORRHAGE 1 0.0000
971 CARDIAC FAILURE 1 0.0000
972 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
973 INFLUENZA LIKE ILLNESS 1 0.0000
974 SKIN EXFOLIATION 1 0.0000
975 DEVICE ISSUE 1 0.0000
976 ADVERSE DRUG REACTION 1 0.0000
977 BREAST CANCER 1 0.0000
978 CARDIAC DISORDER 1 0.0000
979 NEUROPATHY PERIPHERAL 1 0.0000
980 CONTUSION 1 0.0000
981 SYNCOPE 1 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
983 PLATELET COUNT DECREASED 1 0.0000
984 THROMBOCYTOPENIA 1 0.0000
985 EMOTIONAL DISTRESS 1 0.0000
986 RENAL FAILURE 1 0.0000
987 DEATH 6 0.0000
988 HOSPITALISATION 1 0.0000
989 PERIPHERAL SWELLING 1 0.0000
990 DRUG DEPENDENCE 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000